A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases

BACKGROUND: The lack of sufficient specificity and sensitivity among conventional cancer biomarkers, such as prostate specific antigen (PSA) for prostate cancer has been widely recognized after several decades of clinical implications. Autoantibodies (autoAb) among others are being extensively inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Chong, Kim, Hyun J, Haw, Jonathan G, Kalbasi, Anusha, Gardner, Brian K, Li, Gang, Rao, Jianyu, Chia, David, Liong, Monty, Punzalan, Rubio R, Marks, Leonard S, Pantuck, Allan J, de la Taille, Alexandre, Wang, Guomin, Mukouyama, Hideki, Zeng, Gang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102624/
https://www.ncbi.nlm.nih.gov/pubmed/21504557
http://dx.doi.org/10.1186/1479-5876-9-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102624/
https://www.ncbi.nlm.nih.gov/pubmed/21504557
http://dx.doi.org/10.1186/1479-5876-9-43

Ejemplares similares